In addition, studies have reported the relationship between Leptin and post-chemotherapy fatigue in breast cancer, where the expression of Leptin increases during fatigue, and the results suggest that Leptin is a potential biomarker for post-chemotherapy fatigue [19]. This evidence concerns the gene LEP and breast carcinoma.